Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia

Condition:   Bronchopulmonary Dysplasia Intervention:   Biological: Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells Sponsors:   Ottawa Hospital Research Institute;   Canadian Institutes of Health Research (CIHR);   Ontario Institute of Regenerative Medicine (OIRM);   Stem Cell Network Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials